RICHMOND, Calif.--Onyx Pharmaceuticals and the Lawrence Livermore National Laboratory will collaborate on developing a functional genomics system that can be used in expressing, purifying, and characterizing the components of the majority of proteins expressed in humans, known as the human proteome. Information gained on the human proteome will be used in determining the function of genes that encode the proteins, aiding in the understanding of the human genome.